AMCP Leading the way to help patients get the medications they need at a cost they can afford. Join Us Close
Legislation & Regulation
(15 Results)

Biosimilar Drug Therapies

Where We Stand: The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies.

5/20/19

AMCP signs on to stakeholder letter in support of H.R. 6478 - the...

Sign-on letter in support of the Biosimilars Competition Act.

7/26/18

AMCP signs on to stakeholder letter in support of H.R. 6478 - the...

Stakeholder letter expressing support for the Biosimilars Competition Act of 2018.

7/26/18

Biosimilars Will Foster Competition and Lower Costs

AMCP CEO Blog: The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs.

AMCP submits letter to New York Senate committee opposing provisi...

AMCP comment letter on state legislation on medication synchronization.

4/12/18

AMCP submits letter to New Hampshire House committee opposing pro...

AMCP comment letter on New Hampshire legislation on medication synhcronization.

4/12/18

AMCP Submits letter to New Hampshire House Committee recommending...

AMCP comment letter on state legislation on biological products dispensed by pharmacists.

4/5/18